Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer (NCT04446728)
Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer With The Psychosocial Assessment Tool (PAT)
🩺 Plain-English Summary (8th-Grade Level)
The diagnosis and treatment of pediatric cancer adversely affects multiple levels of the social ecology, including patient and caregiver physical and psychosocial health. It is the strong recommendation from the first Standard of the Psychosocial Standards of Care in Pediatric Cancer that cancer centers engage in universal, systematic, psychosocial risk screening for newly diagnosed patients and their families. Universal screening at diagnosis fosters early identification of psychosocial risks and provides the opportunity to match psychosocial care to the level of family need for more equitable, effective and integrated services. However, few programs offer such care in an efficient, comprehensive, and consistent manner, potentially resulting in insufficient care that magnifies inequities in outcomes. To support pediatric cancer centers in their goal of meeting the first Standard of Psychosocial Care, this study will compare two implementation strategies for the Psychosocial Assessment Tool (PAT), a validated parent report screener of family psychosocial risk in English and Spanish, in a cluster randomized trial across 18 pediatric cancer programs in the United States.
Who can join: Review the eligibility criteria below.
Location: Nemours Children's Health — Wilmington, Delaware
🧪 Interventions in This Study
- Training Webinar (BEHAVIORAL)
- Training Webinar Plus Implementation Enhanced Resources (TIER) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Nemours Children's Health — Wilmington, Delaware
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pediatric Cancer
- Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group — Arcadia, California
- Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors — Houston, Texas
- Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images — Memphis, Tennessee
- ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer — Hartford, Connecticut
- Durvalumab and Tremelimumab for Pediatric Malignancies — Baltimore, Maryland
- Medically Tailored Meals for Kids — Chapel Hill, North Carolina
Explore by condition: All Pediatric Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.